Compartir
Neuroprotection of Pioglitazone in Parkinson's Disease (en Inglés)
Janaina Kohl Barbiero de Souza
(Autor)
·
Our Knowledge Publishing
· Tapa Blanda
Neuroprotection of Pioglitazone in Parkinson's Disease (en Inglés) - Kohl Barbiero de Souza, Janaina
Libro Nuevo
Importado
Envío: 18 a 22 días háb.
53,95 €48,55 €
Reseña del libro "Neuroprotection of Pioglitazone in Parkinson's Disease (en Inglés)"
Parkinson's disease, characterised by the degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNpc), is the second neurodegenerative disease after Alzheimer's, affecting approximately 1% of the population aged around 65. The disease is characterised clinically by resting tremor, rigidity, bradykinesia and postural instability. Pioglitazone, a peroxisome proliferator-activated receptor agonist, has been shown to attenuate dopaminergic cell loss in the MPTP animal model of PD, an effect attributed to its anti-inflammatory properties. The present study investigated the motor and cognitive effects obtained by pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, in an intranigral MPTP-induced Parkinson's disease model. Results showed that acute treatment generated some levels of neuroprotection. In contrast, chronic treatment led to a reduction in striatal DA caused by MPTP. These findings suggest that acute administration of pioglitazone 30mg/kg was more effective in generating beneficial effects on motor behaviour and striatal DA levels.
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
Todos los libros de nuestro catálogo son Originales.
El libro está escrito en Inglés.
La encuadernación de esta edición es Tapa Blanda.
✓ Producto agregado correctamente al carro, Ir a Pagar.